Of particular interest in this context is P-glycoprotein (P-gp), which is able to alter the pharmacokinetics of anti-TB drugs, reducing their accumulation in the lungs and macrophages infected with M.tb [11]. This evidence concerns the gene ABCB1 and tuberculosis.